H-1B sponsorship profile: Fulgent Therapeutics, LLC. Across U.S. Department of Labor LCA disclosures, Fulgent Therapeutics, LLC filed 31 Labor Condition Applications covering 31 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 93.5% (29 certified of 31 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Fulgent Therapeutics, LLC’s H-1B petitions range from $63,700 at the low end to $160,000 at the high end, with a petition-weighted average of $103,277. That range reflects the mix of occupations the company sponsors, led by Bioinformatician (8 petitions at $95,216 avg), followed by Senior Bioinformatician and Senior Accountant. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Fulgent Therapeutics, LLC is headquartered in El Monte, CA under NAICS code 621511, and places H-1B workers across 3 states, most heavily in CA, DE, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Fulgent Therapeutics, LLC ranks. By H-1B petition volume, Fulgent Therapeutics, LLC is #7,128 of 119,880 employers nationally and #1,027 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.